|
WO2020248972A1
|
|
Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
|
|
CN111601808A
|
|
Heterocyclic compounds, compositions thereof, and methods of use
|
|
AU2018351559A1
|
|
Heterocyclic compounds, compositions comprising heterocyclic compound, and methods of use thereof
|
|
EP3672973A1
|
|
Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
|
|
US2018169096A1
|
|
Heterocyclic compounds for treating psoriasis
|
|
CN104042582A
|
|
Levetiracetam sustained-release agent composition and preparation method
|
